Medtronic Book Value per Share vs Dividend Yield Analysis

MDT Stock

USD 80.57 1.09 1.37%

Medtronic PLC financial indicator trend analysis is infinitely more than just investigating Medtronic PLC recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medtronic PLC is a good investment. Please check the relationship between Medtronic PLC Book Value Per Share and its Dividend Yield accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.

Book Value Per Share vs Dividend Yield

Book Value per Share vs Dividend Yield Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medtronic PLC Book Value per Share account and Dividend Yield. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Medtronic PLC's Book Value per Share and Dividend Yield is -0.59. Overlapping area represents the amount of variation of Book Value per Share that can explain the historical movement of Dividend Yield in the same time period over historical financial statements of Medtronic PLC, assuming nothing else is changed. The correlation between historical values of Medtronic PLC's Book Value per Share and Dividend Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Book Value per Share of Medtronic PLC are associated (or correlated) with its Dividend Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Dividend Yield has no effect on the direction of Book Value per Share i.e., Medtronic PLC's Book Value per Share and Dividend Yield go up and down completely randomly.

Correlation Coefficient

-0.59

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Dividend Yield

Dividend Yield is Medtronic PLC dividend as a percentage of Medtronic PLC stock price. Medtronic PLC dividend yield is a measure of Medtronic PLC stock productivity, which can be interpreted as interest rate earned on an Medtronic PLC investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Most indicators from Medtronic PLC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medtronic PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.At this time, Medtronic PLC's Tax Provision is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 458.4 M in 2024, whereas Selling General Administrative is likely to drop slightly above 7.5 B in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	21.5B	20.5B	23.6B	24.8B
Total Revenue	31.7B	31.2B	35.9B	37.7B

Gross Profit Total Revenue

Medtronic PLC fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Other Liab	Other Assets	Long Term Debt
Total Assets		0.97	0.7	0.86	0.99	0.94	0.97	0.78	0.69	0.99	0.53	0.5	0.9	0.84	0.97	0.87	0.83	0.75	0.99	0.88	0.15	0.91	0.87	0.82	0.14	0.98
Short Long Term Debt Total	0.97		0.55	0.83	0.93	0.85	0.99	0.83	0.76	0.95	0.62	0.62	0.87	0.76	0.99	0.74	0.69	0.65	1.0	0.9	0.27	0.95	0.75	0.9	0.27	0.98
Other Current Liab	0.7	0.55		0.48	0.76	0.82	0.57	0.56	0.24	0.69	-0.17	0.18	0.73	0.59	0.61	0.83	0.78	0.54	0.61	0.62	-0.42	0.49	0.8	0.32	-0.46	0.66
Total Current Liabilities	0.86	0.83	0.48		0.86	0.82	0.81	0.48	0.71	0.85	0.68	0.41	0.76	0.77	0.75	0.76	0.83	0.71	0.84	0.77	0.53	0.72	0.76	0.7	0.3	0.75
Total Stockholder Equity	0.99	0.93	0.76	0.86		0.97	0.94	0.74	0.64	0.99	0.47	0.42	0.9	0.86	0.94	0.91	0.88	0.79	0.96	0.86	0.08	0.87	0.91	0.77	0.07	0.95
Property Plant And Equipment Net	0.94	0.85	0.82	0.82	0.97		0.87	0.7	0.46	0.94	0.37	0.3	0.91	0.83	0.86	0.98	0.93	0.77	0.89	0.82	-0.03	0.73	0.97	0.62	-0.13	0.89
Net Debt	0.97	0.99	0.57	0.81	0.94	0.87		0.85	0.68	0.96	0.61	0.58	0.89	0.76	0.99	0.78	0.71	0.65	0.99	0.9	0.2	0.93	0.78	0.88	0.2	0.99
Retained Earnings	0.78	0.83	0.56	0.48	0.74	0.7	0.85		0.47	0.75	0.27	0.61	0.78	0.5	0.87	0.59	0.43	0.36	0.82	0.8	-0.03	0.79	0.57	0.73	-0.05	0.86
Cash	0.69	0.76	0.24	0.71	0.64	0.46	0.68	0.47		0.67	0.5	0.68	0.5	0.55	0.7	0.32	0.4	0.43	0.73	0.65	0.56	0.81	0.33	0.78	0.57	0.67
Non Current Assets Total	0.99	0.95	0.69	0.85	0.99	0.94	0.96	0.75	0.67		0.51	0.41	0.86	0.86	0.95	0.87	0.84	0.79	0.97	0.82	0.13	0.91	0.88	0.81	0.15	0.96
Non Currrent Assets Other	0.53	0.62	-0.17	0.68	0.47	0.37	0.61	0.27	0.5	0.51		0.43	0.42	0.47	0.53	0.3	0.3	0.46	0.59	0.51	0.67	0.54	0.33	0.66	0.64	0.5
Cash And Short Term Investments	0.5	0.62	0.18	0.41	0.42	0.3	0.58	0.61	0.68	0.41	0.43		0.52	0.27	0.59	0.15	0.07	0.07	0.58	0.77	0.32	0.58	0.14	0.67	0.3	0.56
Net Receivables	0.9	0.87	0.73	0.76	0.9	0.91	0.89	0.78	0.5	0.86	0.42	0.52		0.73	0.87	0.83	0.79	0.63	0.89	0.92	0.03	0.74	0.81	0.68	-0.06	0.89
Common Stock Shares Outstanding	0.84	0.76	0.59	0.77	0.86	0.83	0.76	0.5	0.55	0.86	0.47	0.27	0.73		0.75	0.78	0.79	0.92	0.79	0.62	0.13	0.73	0.79	0.73	0.18	0.76
Non Current Liabilities Total	0.97	0.99	0.61	0.75	0.94	0.86	0.99	0.87	0.7	0.95	0.53	0.59	0.87	0.75		0.76	0.68	0.65	0.99	0.89	0.12	0.95	0.76	0.88	0.18	1.0
Inventory	0.87	0.74	0.83	0.76	0.91	0.98	0.78	0.59	0.32	0.87	0.3	0.15	0.83	0.78	0.76		0.95	0.75	0.79	0.72	-0.12	0.61	0.99	0.49	-0.22	0.8
Other Current Assets	0.83	0.69	0.78	0.83	0.88	0.93	0.71	0.43	0.4	0.84	0.3	0.07	0.79	0.79	0.68	0.95		0.76	0.74	0.64	0.03	0.58	0.94	0.47	-0.09	0.71
Other Stockholder Equity	0.75	0.65	0.54	0.71	0.79	0.77	0.65	0.36	0.43	0.79	0.46	0.07	0.63	0.92	0.65	0.75	0.76		0.69	0.5	0.07	0.64	0.77	0.56	0.2	0.66
Total Liab	0.99	1.0	0.61	0.84	0.96	0.89	0.99	0.82	0.73	0.97	0.59	0.58	0.89	0.79	0.99	0.79	0.74	0.69		0.9	0.22	0.94	0.8	0.88	0.22	0.99
Total Current Assets	0.88	0.9	0.62	0.77	0.86	0.82	0.9	0.8	0.65	0.82	0.51	0.77	0.92	0.62	0.89	0.72	0.64	0.5	0.9		0.17	0.78	0.7	0.74	0.08	0.89
Short Term Debt	0.15	0.27	-0.42	0.53	0.08	-0.03	0.2	-0.03	0.56	0.13	0.67	0.32	0.03	0.13	0.12	-0.12	0.03	0.07	0.22	0.17		0.24	-0.12	0.38	0.72	0.06
Intangible Assets	0.91	0.95	0.49	0.72	0.87	0.73	0.93	0.79	0.81	0.91	0.54	0.58	0.74	0.73	0.95	0.61	0.58	0.64	0.94	0.78	0.24		0.62	0.93	0.38	0.93
Accounts Payable	0.87	0.75	0.8	0.76	0.91	0.97	0.78	0.57	0.33	0.88	0.33	0.14	0.81	0.79	0.76	0.99	0.94	0.77	0.8	0.7	-0.12	0.62		0.5	-0.19	0.8
Other Liab	0.82	0.9	0.32	0.7	0.77	0.62	0.88	0.73	0.78	0.81	0.66	0.67	0.68	0.73	0.88	0.49	0.47	0.56	0.88	0.74	0.38	0.93	0.5		0.48	0.85
Other Assets	0.14	0.27	-0.46	0.3	0.07	-0.13	0.2	-0.05	0.57	0.15	0.64	0.3	-0.06	0.18	0.18	-0.22	-0.09	0.2	0.22	0.08	0.72	0.38	-0.19	0.48		0.12
Long Term Debt	0.98	0.98	0.66	0.75	0.95	0.89	0.99	0.86	0.67	0.96	0.5	0.56	0.89	0.76	1.0	0.8	0.71	0.66	0.99	0.89	0.06	0.93	0.8	0.85	0.12

Click cells to compare fundamentals

Medtronic PLC Account Relationship Matchups

Medtronic PLC fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	90.7B	93.1B	91.0B	90.9B	104.6B	109.8B
Short Long Term Debt Total	24.8B	26.4B	24.1B	24.4B	28.0B	29.4B
Other Current Liab	5.6B	6.1B	6.1B	6.1B	7.0B	7.3B
Total Current Liabilities	10.4B	8.5B	12.4B	9.1B	10.4B	10.9B
Total Stockholder Equity	50.7B	51.4B	52.6B	51.5B	59.2B	62.2B
Property Plant And Equipment Net	4.8B	5.2B	5.4B	5.6B	6.4B	6.7B
Net Debt	20.7B	22.8B	20.4B	22.8B	26.2B	27.6B
Retained Earnings	28.1B	28.6B	30.3B	30.4B	35.0B	36.7B
Cash	4.1B	3.6B	3.7B	1.5B	1.8B	1.6B
Non Current Assets Total	68.7B	70.5B	67.9B	69.3B	79.7B	83.6B
Non Currrent Assets Other	1.6B	1.7B	2.0B	2.3B	2.7B	2.8B
Cash And Short Term Investments	10.9B	10.8B	10.6B	8.0B	9.2B	4.8B
Net Receivables	4.6B	5.5B	5.6B	6.0B	6.9B	7.2B
Common Stock Shares Outstanding	1.4B	1.4B	1.4B	1.3B	1.5B	1.2B
Liabilities And Stockholders Equity	90.7B	93.1B	91.0B	90.9B	104.6B	109.8B
Non Current Liabilities Total	29.5B	33.0B	25.9B	30.2B	34.8B	36.5B
Inventory	4.2B	4.3B	4.6B	5.3B	6.1B	6.4B
Other Current Assets	2.2B	2.0B	2.3B	2.4B	2.8B	2.9B
Other Stockholder Equity	26.2B	26.3B	24.6B	24.6B	28.3B	29.7B
Total Liab	39.8B	41.5B	38.3B	39.3B	45.2B	47.4B
Total Current Assets	22.0B	22.5B	23.1B	21.7B	24.9B	26.2B
Short Term Debt	2.8B	11M	3.7B	20M	23M	21.9M
Intangible Assets	19.1B	17.7B	15.6B	14.8B	17.1B	17.9B
Accounts Payable	2.0B	2.1B	2.3B	2.7B	3.1B	3.2B
Other Liab	6.7B	5.8B	5.5B	6.8B	7.8B	3.9B
Other Assets	2.1B	3.5B	1M	(1M)	(1.2M)	(1.1M)
Long Term Debt	22.0B	26.4B	20.4B	24.3B	28.0B	29.4B
Good Will	39.8B	42.0B	40.5B	41.4B	47.6B	50.0B
Short Term Investments	6.8B	7.2B	6.9B	6.4B	7.4B	5.0B
Accumulated Other Comprehensive Income	(3.6B)	(3.5B)	(2.3B)	(3.5B)	(3.1B)	(3.0B)
Common Stock	134.1K	134.5K	133.1K	133.1K	119.8K	113.8K
Property Plant Equipment	4.8B	6.2B	5.4B	6.6B	7.6B	8.0B
Property Plant And Equipment Gross	5.8B	5.2B	13.4B	14.1B	16.2B	17.0B
Short Long Term Debt	2.8B	11M	3.7B	20M	18M	17.1M
Net Tangible Assets	50.7B	(8.3B)	(3.5B)	51.5B	59.2B	62.2B
Deferred Long Term Liab	1.2B	1.0B	884M	708M	637.2M	605.3M
Noncontrolling Interest In Consolidated Entity	135M	174M	171M	182M	209.3M	123.1M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Medtronic PLC is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medtronic Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medtronic Plc Stock. Highlighted below are key reports to facilitate an investment decision about Medtronic Plc Stock:

How To Invest In Medtronic

Details

Is Medtronic Stock a good investment?

Details

What is Medtronic PLC's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.

Note that the Medtronic PLC information on this page should be used as a complementary analysis to other Medtronic PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Medtronic Stock analysis

When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.

	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Transaction History View history of all your transactions and understand their impact on performance
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Stocks Directory Find actively traded stocks across global markets

Is Medtronic PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medtronic PLC. If investors know Medtronic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medtronic PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.078

Dividend Share

2.75

Earnings Share

3.15

Revenue Per Share

24.298

Quarterly Revenue Growth

0.047

The market value of Medtronic PLC is measured differently than its book value, which is the value of Medtronic that is recorded on the company's balance sheet. Investors also form their own opinion of Medtronic PLC's value that differs from its market value or its book value, called intrinsic value, which is Medtronic PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medtronic PLC's market value can be influenced by many factors that don't directly affect Medtronic PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Medtronic PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medtronic PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medtronic PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Medtronic Book Value per Share vs Dividend Yield Analysis

Book Value Per Share vs Dividend Yield

Book Value per Share vs Dividend Yield Correlation Analysis

Correlation Coefficient

Book Value Per Share

Dividend Yield

Medtronic PLC fundamental ratios Correlations

Medtronic PLC Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Medtronic PLC fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Medtronic Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Short Long Term Debt Total
Long Term Debt	+ 1.0	Non Current Liabilities Total
Total Stockholder Equity	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Assets
Net Debt	+ 0.99	Short Long Term Debt Total

Other Assets	- 0.46	Other Current Liab
Short Term Debt	- 0.42	Other Current Liab
Other Assets	- 0.22	Inventory
Other Assets	- 0.19	Accounts Payable
Non Currrent Assets Other	- 0.17	Other Current Liab
Other Assets	- 0.13	Property Plant And Equipment Net